Effects of fosinopril on renal function, baroreflex response and noradrenaline pressor response in conscious normotensive dogs

Veterinary Research Communications

Volumn 25, Issue 5, 2001, Pages 355-366

  Buranakarl, C ^a   Kijtawornrat, A ^a   Nampimoon, P ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Arterial pressure; Dog; Electrolyte; Excretion; Fosinopril; Glomerular filtration; Heart rate; Renal haemodynamics

Indexed keywords

FOSINOPRIL; NORADRENALIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOG; DRUG EFFECT; DRUG SCREENING; KIDNEY FUNCTION; MALE; NONHUMAN; PRESSOR RESPONSE; PRESSORECEPTOR REFLEX; SODIUM EXCRETION;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BAROREFLEX; BLOOD PRESSURE; DOGS; FOSINOPRIL; GLOMERULAR FILTRATION RATE; HEART RATE; HEMATOCRIT; KIDNEY; MALE; NOREPINEPHRINE; VASOCONSTRICTOR AGENTS;

ANIMALIA; CANIS FAMILIARIS;

EID: 0034952288     PISSN: 01657380     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1010638609216     Document Type: Article

References (31)

1. Vascular wall renin in spontaneously hypertensive rats: Potential relevance to hypertension maintenance and antihypertensive effect of captopril
2. Effects of nonpeptide angiotensin II receptor antagonist DuP753 on blood pressure and renal functions in spontaneously hypertensive PH dogs
3. A rapid method for the determination of para-aminohippuric acid in kidney function tests
4. Hypertension of renal origin: Evidence for two different mechanisms
5. Use of angiotensin II antagonists in experimental hypertension
6. Renal hemodynamics and renal kinins after angiotensin converting enzyme inhibitor
7. Interaction of angiotensin converting enzyme inhibitors with the function of the sympathetic nervous system
8. Renal response to captopril in conscious dogs pretreated with indomethacin
9. Fosinopril, a phosphinic acid inhibitor of angiotensin I converting enzyme: In vitro and pre-clinical in vivo pharmacology
10. Blood pressure lowering and renal hemodynamic effects of fosinopril in conscious animal models
11. Facilitation of noradrenergic transmission by angiotensin in hypertensive rats
12. Combined versus single effect of fosinopril and hydrochlorothiazide in hypertensive patients
13. Comparison of some pharmacokinetic parameters of 5 angiotensin-converting enzyme inhibitors in normal beagles
14. Clinical pharmacokinetics of angiotensin converting enzyme (ACE) inhibitors in renal failure
15. Pressor responses to norepinephrine in rabbits with 3 days and 30 days renal artery stenosis: The role of angiotensin II
16. Clinical pharmacokinetics of the newer ACE inhibitors: A review
17. Effect of intrarenal angiotensin II blockade on renal function in conscious dogs
18. Angiotensin and the cardiac baroreflex response to phenylephrine
19. Racial differences in the renal response to blood pressure lowering during chronic angiotensin-converting enzyme inhibitor: A prospective double blind randomized comparison of fosinopril and lisinopril in older hypertensive patients with chronic renal insufficiency
20. Fosinopril: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in essential hypertension
21. Immediate and short-term cardiovascular effects of fosinopril, a new angiotensin-converting enzyme inhibitor, in patients with essential hypertension
22. Intravertebral angiotensin II inhibits cardiac vagal efferent activity in dogs
23. Analysis of the action of angiotensin II on the baroreflex control of heart rate in conscious rabbits
24. Effects of low and high doses of fosinopril on the structure and function of resistance arteries
25. Renin activity of the kidney in the spontaneously hypertensive rat
26. Mechanisms of action of enalapril in experimental hypertension and acute left ventricular failure
27. Fosinopril: A new generation of angiotensin-converting enzyme inhibitors
28. An anthrone procedure for determination of inulin in biological fluids
29. Blockade of adrenergic potentiation effect of angiotensin by 1-sar-8-ala-angiotensin II
30. Adrenergic facilitation by angiotensin: Does it serve a physiological function?